Ketogenic diet attenuates post-cardiac arrest brain injury by upregulation of pentose phosphate pathway–mediated antioxidant defense in a mouse model of cardiac arrest

[Display omitted] •Post-cardiac arrest brain injury can be attenuated by ketogenic diet.•Ketogenic diet suppresses glucose oxidation in the brain.•Ketogenic diet activates pentose phosphate pathway-mediated antioxidant system. The aim of this study was to investigate the effect of the ketogenic diet...

Full description

Saved in:
Bibliographic Details
Published inNutrition (Burbank, Los Angeles County, Calif.) Vol. 103-104; p. 111814
Main Authors Peng, Fei, Zhang, Yu-Han, Zhang, Lu, Yang, Man, Chen, Chan, Yu, Hai, Li, Tao
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2022
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •Post-cardiac arrest brain injury can be attenuated by ketogenic diet.•Ketogenic diet suppresses glucose oxidation in the brain.•Ketogenic diet activates pentose phosphate pathway-mediated antioxidant system. The aim of this study was to investigate the effect of the ketogenic diet (KD) on post-cardiac arrest brain injury in a mouse model of cardiac arrest and cardiopulmonary resuscitation. Mice were fed a KD for 4 wk and then subjected to cardiac arrest and cardiopulmonary resuscitation. The HT22 cells after β-hydroxybutyrate (β-OHB) treatment were exposed to oxygen-glucose deprivation/reoxygenation. Survival and neurologic function were measured after return of spontaneous circulation. Positron emission tomography/computed tomography scanning, 13C-magnetic resonance spectroscopy analysis, and seahorse assay were performed to explore the mechanism underlying the phenotype. Results of this study demonstrated that KD improved neurologic function and reduced apoptotic neurons in cardiac arrest and cardiopulmonary resuscitation mice. With no alteration of glucose uptake, KD suppressed glucose oxidation in mouse brain. Consistently, the glycolytic capacity of the HT22 cells was also downregulated by β-OHB treatment. Moreover, KD increased nicotinamide adenine dinucleotide phosphate/oxidized nicotinamide adenine dinucleotide phosphate and reduced glutathione/oxidized glutathione couples and reduced reactive oxygen species in the brain, probably due to activation of glucose-6-phosphate dehydrogenase, the rate-limiting enzyme in the pentose phosphate pathway. Pharmacologic inhibition of pentose phosphate pathway totally abolished the influence of β-OHB on glycolysis, and post–oxygen-glucose deprivation/reoxygenation cell viability and reactive oxygen species production in HT22 cells. KD improved survival and attenuated post-cardiac arrest brain injury, which was mediated by upregulation of pentose phosphate pathway and related antioxidant defense system.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0899-9007
1873-1244
DOI:10.1016/j.nut.2022.111814